Med. praxi. 2023;20(4):212-218 | DOI: 10.36290/med.2023.035

Herpes zoster, symptoms and therapy

MUDr. et MUDr. Pavel Konrád
Kožní ambulance, Černošice
LaserMed, s. r. o., Praha

Shingles (herpes zoster) is an acute segmental disease with skin and neurological manifestations, usually typical of the clinical picture and course, which is caused by the varicella-zoster virus (VZV) of the herpesvirus group. It is an expression of reactivation of the virus, which persists in the sensitive ganglia of the human body after primoinfection with chickenpox. Reactivation occurs as a result of immunosuppression due to age, disease, immunosuppressive treatment or another stress factor. Since it is classified as precancerous, screening patients is recommended after shingles. The course of the diseases may be more severe in individuals with a compromised immune system, and it may even be associated with serious to fatal complications. Due to the location of the process, the course of herpes zoster trigeminalis is accompanied by additional symptoms, the most serious of which may involve eye problems and extreme trigeminal pain. Inadequate or late onset of therapy results in postherpetic neuralgia. Due to the intensity and the fact that it may even last several months, they are very bothersome and debilitating. In the older literature, shingles is even classified as a cause of suicide. Much progress has been made in the prevention of shingles in recent years. This article discusses the etiology, clinical signs, and current therapeutic recommendations.

Keywords: shingles, clinical picture, treatment.

Accepted: June 23, 2023; Published: September 26, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Konrád P. Herpes zoster, symptoms and therapy. Med. praxi. 2023;20(4):212-218. doi: 10.36290/med.2023.035.
Download citation

References

  1. Braun­‑Falco O, Plewig G, Wolf H. Dermatológia a venerológia. Martin: Osveta; 2001.
  2. Pospíšilová A. Herpes zoster. Med. praxi. 2009;6(1):38-41.
  3. [Internet] Holub M. Herpeticke infekce. Available from:.http://zdravi.euro.cz/clanek/priloha­‑lekarske­­‑listy/herpeticke­‑infekce-419306.
  4. Schimerová P. Herpes zoster - klinický obraz, možnosti terapie a prevence. Dermatol. praxi. 2017;11(3):115-119. Go to original source...
  5. Roháčová H. Pásový opar a současný pohled na jeho léčbu. Dermatol. praxi. 2015;9(3):165-166.
  6. Boštíková P. Vybrané virové a bakteriální perinatálně přenosné infekce - 2. část: Herpetické viry. Pediatr. praxi. 2015;16(4):227-230.
  7. Zimová J. Herpes zoster - pásový opar aktuálně a přehledně. Dematol. praxi. 2012;6(2):91-99.
  8. Štrofová H, Svozílková P. Herpes zoster virus a oční postižení. Interní Med. 2014;16(4):159-162.
  9. SPC Herpesin 400 mg, říjen 2020.
  10. SPC Valaciclovir Mylan 500 mg, prosinec 2022.
  11. SPC Valtrex, září 2021.
  12. SPC Zostevir, 15. 1. 2016.
  13. SPC Shingrix, prosinec 2022.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.